Euroapi S.A. (EAPIF)
Euroapi S.A. operates in the Medical - Devices industry of the Healthcare sector, headquartered in Paris, IF, FR. The stock last traded at $1.17, up 0.00% on the session, giving a market capitalisation of $111.8M. On trailing twelve-month figures it carries a trailing P/E of -0.29, a net margin of -40.9%. Its beta of 0.98 implies it has historically moved less than the broad market.
Established in 2021 and headquartered in Paris, France, Euroapi SA specializes in the end-to-end process, from development and manufacturing to marketing and distribution, of active pharmaceutical ingredients (APIs) and various intermediary compounds. These essential materials are then utilized in the formulation of a wide array of medicinal products for both human and veterinary applications.
Euroapi S.A. is most often compared with the following Healthcare names: